Matthew K Fust - Net Worth and Insider Trading

Over the past 18 months, Matthew K Fust made 1 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 12,195. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .

In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew K Fust made 1 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 60,000. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 159,049 shares made by Marc Wilson , and a net sale of 91,672 shares made by Dana Pizzuti .

In summary, during the past 3 months, insiders sold 46,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 46,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew K Fust made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .

In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew K Fust made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .

In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.

Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew K Fust made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Matthew K Fust made 1 insider transaction in Neumora Therapeutics Inc (NMRA) with a net sale of 21,788. Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net sale of 88,235 shares made by Robert A. Lenz .

In summary, during the past 3 months, insiders sold 210,023 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 210,023 shares. During the past 18 months, 210,023 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,083,810 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.